Article thumbnail

Quantification of phosphorylated metabolites based on <sup>31</sup>P spectra for different tissue samples and experimental groups.

By Rui V. Simões (126313), Miquel E. Cabañas (6160655), Carla Loreiro (6160658), Miriam Illa (185342), Fatima Crispi (373448) and Eduard Gratacós (3128295)


<p>Values displayed as metabolite peak areas normalized to sample weight (average ±SD) for brain (<b>A</b>) and heart (<b>B</b>) samples of CTR, GLC and ACE groups. PC could not be quantified properly in heart samples due to overlap with 2,3-diphosphoglycerate (<a href="" target="_blank">Fig 5</a>). Significant differences between AGA and FGR subjects are indicated (* p<0.05, two-tailed unpaired t-Test).</p

Topics: Biochemistry, Medicine, Cell Biology, Molecular Biology, Physiology, Developmental Biology, Cancer, Computational Biology, AGA, Lac C 2C, 13 C-labelled substrate infusions, term FGR fetuses, gestation, 2 D spectra, cell membrane turnover, rabbit model, growth restriction, New Zealand rabbits, heart apex regions, metabolism, vivo multinuclear HRMAS Background, phospholipid breakdown products, non-infused control hearts, multinuclear 1 D
Year: 2018
DOI identifier: 10.1371/journal.pone.0208784.g006
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.